These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38371565)

  • 1. Comparison of Oral Azathioprine and Oral Mini Pulse Steroid in the Treatment of Vitiligo: An Open-Label Randomized Controlled Trial.
    Jawade S; Saoji V; Madke B; Singh A
    Indian J Dermatol; 2023; 68(6):591-597. PubMed ID: 38371565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral mycophenolate mofetil as a stabilizing treatment for progressive non-segmental vitiligo: results from a prospective, randomized, investigator-blinded pilot study.
    Bishnoi A; Vinay K; Kumaran MS; Parsad D
    Arch Dermatol Res; 2021 Jul; 313(5):357-365. PubMed ID: 32737577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris.
    Singh A; Kanwar AJ; Parsad D; Mahajan R
    Indian J Dermatol Venereol Leprol; 2014; 80(1):29-35. PubMed ID: 24448120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Comparative Study of Oral Corticosteroid Minipulse and Low-Dose Oral Methotrexate in the Treatment of Unstable Vitiligo.
    Singh H; Kumaran MS; Bains A; Parsad D
    Dermatology; 2015; 231(3):286-90. PubMed ID: 26278124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients.
    Radmanesh M; Saedi K
    J Dermatolog Treat; 2006; 17(3):151-3. PubMed ID: 16854754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety Comparison of Basic Fibroblast Growth Factor-Related Decapeptide 0.1% Solution (bFGFrP) Plus Oral PUVA Combination Therapy with Oral PUVA Monotherapy in the Treatment of Vitiligo.
    Nayak CS; Kura MM; Banerjee G; Patil SP; Deshpande A; Sekar S; Sharma A; Pathak R; Sarma P
    J Cutan Aesthet Surg; 2023; 16(1):28-33. PubMed ID: 37383981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical tacrolimus 0.03% monotherapy in the treatment of non-segmental vitiligo: a randomized, controlled trial.
    Saleh R; Ahmed AA; M Abd-Elmagid W
    J Cosmet Dermatol; 2021 Dec; 20(12):3943-3952. PubMed ID: 33657259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood vitiligo: response to methylprednisolone oral minipulse therapy and topical fluticasone combination.
    Majid I; Masood Q; Hassan I; Khan D; Chisti M
    Indian J Dermatol; 2009; 54(2):124-7. PubMed ID: 20101306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Betamethasone Valerate 0.1% Cream Twice Daily Plus Oral Simvastatin Versus Betamethasone Valerate 0.1% Cream Alone in the Treatment of Vitiligo Patients.
    Iraji F; Banihashemi SH; Faghihi G; Shahmoradi Z; Tajmirriahi N; Jazi SB
    Adv Biomed Res; 2017; 6():34. PubMed ID: 28516068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III-V): A double-blind, randomized, placebo-controlled, prospective, multicenter study.
    Esmat SM; El-Mofty M; Rasheed H; Mostafa WZ; Anbar TS; Abdallah M; Bassiouny D; Abdel-Halim D; Hegazy R; Eid AA; Nassar A; Abdel-Aziz RT; Fawzy MM; Gawdat HI; El Hawary M; Sany I; Shalaby S; Ragab N; Abdel-Gaber RM; Tawfik YM; El-Bassiouny M; El-Husseiny R; Attia MS; Farid C; Genedy RM; Mogawer RM
    Photodermatol Photoimmunol Photomed; 2022 May; 38(3):277-287. PubMed ID: 34726808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease.
    Pasricha JS; Khaitan BK
    Int J Dermatol; 1993 Oct; 32(10):753-7. PubMed ID: 8225724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: A randomized, double-blind, placebo-controlled trial.
    Charoenpongpun N; Kamanamool N; Udompataikul M; Khunkhet S; Kanokrungsee S
    Dermatol Ther; 2022 Aug; 35(8):e15596. PubMed ID: 35608017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo.
    Jafarzadeh A; Pour Mohammad A; Khosravi M; Amiri S; Rasouli A; Keramati H; Goodarzi A
    Skin Res Technol; 2024 Mar; 30(3):e13642. PubMed ID: 38454597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional Carbon Dioxide Laser versus Fractional Carbon Dioxide Laser with Autologous Intralesional Platelet-rich Plasma in the Treatment of Stable, Non-segmental Vitiligo: A Randomized Comparative Study.
    Raizada A; Panda M; Singh BS; Kar BR
    J Cutan Aesthet Surg; 2021; 14(1):55-63. PubMed ID: 34084009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad / narrow band UVB phototherapy in progressive vitiligo.
    Rath N; Kar HK; Sabhnani S
    Indian J Dermatol Venereol Leprol; 2008; 74(4):357-60. PubMed ID: 18797057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo: a retrospective comparative analysis of treatment modalities in 500 patients.
    Handa S; Pandhi R; Kaur I
    J Dermatol; 2001 Sep; 28(9):461-6. PubMed ID: 11603385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of systemic steroids and phototherapy in the treatment of stable vitiligo: a randomized controlled trial.
    El Mofty M; Essmat S; Youssef R; Sobeih S; Mahgoub D; Ossama S; Saad A; El Tawdy A; Mashaly HM; Saney I; Helal R; Shaker O
    Dermatol Ther; 2016 Nov; 29(6):406-412. PubMed ID: 27528547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial.
    Rosmarin D; Pandya AG; Lebwohl M; Grimes P; Hamzavi I; Gottlieb AB; Butler K; Kuo F; Sun K; Ji T; Howell MD; Harris JE
    Lancet; 2020 Jul; 396(10244):110-120. PubMed ID: 32653055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study.
    Nisticò S; Chiricozzi A; Saraceno R; Schipani C; Chimenti S
    Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.